Pangen Biotech Inc.
Develops and manufactures biopharmaceuticals and offers CDMO services.
222110 | KO
Overview
Corporate Details
- ISIN(s):
- KR7222110009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) , 수원시
- Sector:
- Manufacturing
Description
Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2022-12-09 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 104.4 KB | ||
| 2022-12-09 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB | ||
| 2022-11-30 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB | ||
| 2022-11-30 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 111.4 KB | ||
| 2022-11-29 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 82.7 KB | ||
| 2022-11-22 00:00 |
최대주주변경을수반하는주식양수도계약체결
|
Korean | 29.1 KB | ||
| 2022-11-22 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 23.6 KB | ||
| 2022-11-22 00:00 |
주주총회소집결의
|
Korean | 6.9 KB | ||
| 2022-11-22 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2022-11-22 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 123.3 KB | ||
| 2022-11-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.9 KB | ||
| 2022-11-21 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 26.2 KB | ||
| 2022-11-11 00:00 |
분기보고서 (2022.09)
|
Korean | 1.0 MB | ||
| 2022-10-25 00:00 |
투자판단관련주요경영사항(빈혈치료제인 에리사(ERYSAA 2000IU) 필리핀 품목허가 획득)
|
Korean | 6.8 KB |
Automate Your Workflow. Get a real-time feed of all Pangen Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pangen Biotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pangen Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
